68Ga-DOTATATE PET/CT

You have access
False-Positive ⁶⁸Ga-DOTATATE PET/CT Findings in Hereditary Hypophosphatemia–Osteomalacia Mimicking Culprit Lesions of Tumor-Induced Osteomalacia
Rahul V. Parghane and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2023, 51 (1) 73-74; DOI: https://doi.org/10.2967/jnmt.121.263776
You have access
Combined ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2020, 48 (3) 292-294; DOI: https://doi.org/10.2967/jnmt.119.237354
You have access
⁶⁸Ga-DOTATATE PET/CT Can Be an Alternative Imaging Method in Insulinoma Patients
Sadiye Altun Tuzcu, Zafer Pekkolay, Faruk Kılınç and Alpaslan Kemal Tuzcu

Journal of Nuclear Medicine Technology September 1, 2017, 45 (3) 198-200; DOI: https://doi.org/10.2967/jnmt.117.192708
You have access
MIB-1 Index–Stratified Assessment of Dual-Tracer PET/CT with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting
Nikita Sampathirao and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2017, 45 (1) 34-41; DOI: https://doi.org/10.2967/jnmt.116.185777
You have access
¹⁷⁷Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors
Sandip Basu and Preeti Fargose

Journal of Nuclear Medicine Technology December 1, 2016, 44 (4) 248-250; DOI: https://doi.org/10.2967/jnmt.116.177873
You have access
Rare Occurrence of Hypergastrinemia Due to Thoracic Neuroendocrine Tumor: Detection and Characterization by ⁶⁸Ga-DOTATATE PET/CT
Nikita Sampathirao and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2016, 44 (3) 203-204; DOI: https://doi.org/10.2967/jnmt.115.171603

Main menu

User menu

Search

68Ga-DOTATATE PET/CT